SCHEMBL13428442

SCHEMBL13428442

CN(Cc1ccccc1)C[C@H](N)CCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.49
CARM1 Q86X55 1/20 0.49
PRMT6 Q96LA8 1/20 0.49
PRMT8 Q9NR22 1/20 0.49
AOC3 Q16853 3/20 0.46
ALDH1A1 P00352 3/20 0.44
TSHR P16473 2/20 0.44
LMNA P02545 2/20 0.43
USP2 O75604 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
PYCR1 P32322 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
DNM1 Q05193 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
BLM P54132 1/20 0.42
TAAR1 Q96RJ0 1/20 0.41
ANPEP P15144 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171478 0.84 TAAR1 (0.50) SIGMAR1AOC3ALDH1A1TSHRTAAR1
SCHEMBL172954 0.84 TAAR1 (0.50) SIGMAR1AOC3ALDH1A1TSHRTAAR1
SCHEMBL4700576 0.84 TAAR1 (0.50) SIGMAR1AOC3ALDH1A1TSHRTAAR1
SCHEMBL11116432 0.82 EPHX1 (0.57) SIGMAR1CARM1PRMT6PRMT8AOC3
SCHEMBL13428461 0.82 CARM1 (0.52) SIGMAR1CARM1PRMT6PRMT8AOC3
SCHEMBL21910026 0.82 CARM1 (0.52) SIGMAR1CARM1PRMT6PRMT8AOC3
SCHEMBL25072138 0.82 CARM1 (0.45) SIGMAR1CARM1PRMT6PRMT8AOC3
SCHEMBL12494806 0.79 DNM1 (0.56) SIGMAR1CARM1PRMT6PRMT8ALDH1A1
SCHEMBL16209876 0.78 CARM1 (0.55) SIGMAR1CARM1PRMT6PRMT8AOC3
SCHEMBL1006191 0.78 CARM1 (0.55) SIGMAR1CARM1PRMT6PRMT8AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS ASTELLAS PHARMA INC. (JP) 2010-03-18 US disclosed
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS ASTELLAS PHARMA INC. (JP) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069388-A1 N-HYDROXYACRYLAMIDE COMPOUNDS HDAC1, HDAC11, HDAC2 SIGMAR1 1900/4885CARM1 14/4885PRMT6 425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.